LOWELL HAYS: Open Payments
NPI 1639111511 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 49 payments from 11 companies in 2025. Trend: 2023 $1,004 · 2024 $2,114 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $207 |
| Novo Nordisk Inc | 7 | $168 |
| Exact Sciences Corporation | 6 | $152 |
| Lilly USA, LLC | 6 | $118 |
| Amgen Inc. | 5 | $77 |
| PFIZER INC. | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Abbott Laboratories | 3 | $69 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: Cologuard Collection Kit, FARXIGA, OTEZLA, FREESTYLE LIBRE 3, AIRSUPRA, MOUNJARO, Rybelsus, Ozempic.
Industry payments across TX — which companies pay providers there.
